Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man

Currently, no vaccine exists for hepatitis C virus (HCV), a major pathogen thought to infect 170 million people globally. Many studies suggest that host T cell responses are critical for spontaneous resolution of disease, and preclinical studies have indicated a requirement for T cells in protection...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Barnes, E, Folgori, A, Capone, S, Swadling, L, Aston, S, Kurioka, A, Meyer, J, Huddart, R, Smith, K, Townsend, R, Brown, A, Antrobus, R, Ammendola, V, Naddeo, M, O'Hara, G, Willberg, C, Harrison, A, Grazioli, F, Esposito, M, Siani, L, Traboni, C, Oo, Y, Adams, D, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	American Association for the Advancement of Science 2012

Míreanna comhchosúla

A highly immunogenic novel genetic vaccine against HCV
de réir: Del Sorbo, M, et al.
Foilsithe / Cruthaithe: (2012)

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
de réir: Kelly, C, et al.
Foilsithe / Cruthaithe: (2011)

Hepatitis Hide and Seek
de réir: Barnes, E, et al.
Foilsithe / Cruthaithe: (2012)

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.
de réir: Colloca, S, et al.
Foilsithe / Cruthaithe: (2012)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
de réir: Barnes, E, et al.
Foilsithe / Cruthaithe: (2011)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
de réir: Folgori, A, et al.
Foilsithe / Cruthaithe: (2009)

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
de réir: Swadling, L, et al.
Foilsithe / Cruthaithe: (2014)

IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
de réir: Kelly, C, et al.
Foilsithe / Cruthaithe: (2012)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
de réir: Capone, S, et al.
Foilsithe / Cruthaithe: (2010)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
de réir: Capone, S, et al.
Foilsithe / Cruthaithe: (2010)

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans
de réir: Kelly, C, et al.
Foilsithe / Cruthaithe: (2016)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
de réir: Barnes, E, et al.
Foilsithe / Cruthaithe: (2009)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
de réir: Green, C, et al.
Foilsithe / Cruthaithe: (2015)

Chronic Hepatitis C Virus infection subverts vaccine induced T-cell immunity in humans.
de réir: Kelly, C, et al.
Foilsithe / Cruthaithe: (2016)

Highly immunogenic virally vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
de réir: Swadling, L, et al.
Foilsithe / Cruthaithe: (2016)

Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
de réir: Swadling, L, et al.
Foilsithe / Cruthaithe: (2016)

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
de réir: Draper, S, et al.
Foilsithe / Cruthaithe: (2010)

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
de réir: Ewer, K, et al.
Foilsithe / Cruthaithe: (2013)

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
de réir: Leo Swadling, et al.
Foilsithe / Cruthaithe: (2016-08-01)

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.
de réir: Spencer, A, et al.
Foilsithe / Cruthaithe: (2014)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
de réir: O'Hara, G, et al.
Foilsithe / Cruthaithe: (2012)

Innate‐like CD8+ T‐cells and NK cells: converging functions and phenotypes
de réir: Kurioka, A, et al.
Foilsithe / Cruthaithe: (2018)

Prime-boost vectored malaria vaccines: progress and prospects.
de réir: Hill, A, et al.
Foilsithe / Cruthaithe: (2010)

Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.
de réir: Kelly, C, et al.
Foilsithe / Cruthaithe: (2015)

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.
de réir: Reyes-Sandoval, A, et al.
Foilsithe / Cruthaithe: (2010)

Erratum: Prime-boost immunization with adenoviral and modified vaccinia virus ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses
de réir: Reyes-Sandoval, A, et al.
Foilsithe / Cruthaithe: (2011)

Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8(+) T-Cell Responses, (vol 78, pg 152, 2010)
de réir: Reyes-Sandoval, A, et al.
Foilsithe / Cruthaithe: (2011)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
de réir: Alessandra Vitelli, et al.
Foilsithe / Cruthaithe: (2017-12-01)

A monovalent chimpanzee adenovirus Ebola vaccine — preliminary report
de réir: Rampling, T, et al.
Foilsithe / Cruthaithe: (2015)

Erratum: MAIT cells: new guardians of the liver.
de réir: Kurioka, A, et al.
Foilsithe / Cruthaithe: (2017)

MAIT cells: new guardians of the liver
de réir: Kurioka, A, et al.
Foilsithe / Cruthaithe: (2016)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
de réir: Cottingham, MG, et al.
Foilsithe / Cruthaithe: (2012)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
de réir: Cottingham, MG, et al.
Foilsithe / Cruthaithe: (2011)

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults.
de réir: Green, C, et al.
Foilsithe / Cruthaithe: (2015)

Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.
de réir: Federico Napolitano, et al.
Foilsithe / Cruthaithe: (2021-04-01)

MAIT cells induce proinflammatory cytokine production in monocytes through the secretion of granzymes A and K
de réir: Kurioka, A, et al.
Foilsithe / Cruthaithe: (2012)

MAIT cells induce proinflammatory cytokine production in monocytes through the secretion of granzymes A and K
de réir: Kurioka, A, et al.
Foilsithe / Cruthaithe: (2011)

A novel model of MHC class I-related (MR1)-mediated activation of MAIT cells
de réir: Ussher, J, et al.
Foilsithe / Cruthaithe: (2012)

CD161(++)CD8(+) T cells express IFNgamma in response to TLR8 stimulation in an IL-12(+) IL-18 dependent, TCR independent, manner
de réir: Willberg, C, et al.
Foilsithe / Cruthaithe: (2012)

Induction and maintenance of CX3CR1-intermediate peripheral memory CD8+ T cells by persistent viruses and vaccines
de réir: Gordon, C, et al.
Foilsithe / Cruthaithe: (2018)